NVision

NVision develops quantum-enabled platforms for healthcare and scientific computing. Its POLARIS system applies parahydrogen-induced polarization to amplify the magnetic signal of natural metabolites by more than ten thousand times, allowing standard MRI scanners to measure cellular-level metabolism, with an initial focus on cancer imaging and treatment monitoring.

The company also builds PIQC, a quantum computing architecture based on engineered organic molecules that pair long-lived nuclear-spin qubits with native photonic interfaces so they can be deposited onto photonic integrated circuits. Both platforms grew out of corporate research into room-temperature hyperpolarization for metabolic imaging, which the company says also led to a molecular qubit with a spin-photon interface.